Treatment of Complicated Staphylococcus aureus Bacteremia
JAMA Clinical Reviews
00:00
Evaluating Dablovancin: Efficacy and Safety in Staphylococcus Aureus Bacteremia Treatment
This chapter examines the DOTS trial findings on dablovancin's effectiveness and safety compared to standard prolonged IV antibiotics for Staphylococcus aureus bacteremia. It highlights the non-inferiority of dablovancin and raises questions about its impact on patients' quality of life, suggesting a need for further exploration.
Transcript
Play full episode
